We’re excited to announce two new additions to our board following on from our investment earlier this year. We’re delighted to formalise our relationship with Stephen Roe who has been appointed Chairman. Stephen has been working with the OGI Bio founders informally since before we formed the company, and we’re delighted he’s agreed to join us as Chairman to steer us on this journey. We’re also excited to welcome Michiel Smith as Investor Director. Michiel brings a wealth of commercial and financial experience to our board.
“We are excited to welcome Stephen and Michiel to our board,” said Alex McVey, CEO of OGI Bio. “Their combined experience and leadership will play a crucial role in our journey to transform microbial research through innovative automation.”
These appointments mark an important step in OGI Bio’s mission to empower researchers and redefine the possibilities in biotechnology.